DMAC
insider transactionsDiaMedica Therapeutics Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
40.4K sh
Own New
-
Grant·A
President & CEO
$0
380.0K sh
Own New
-
Grant·A
Director
$0
51.2K sh
Own New
-
Grant·A
Director
$0
40.4K sh
Own New
-
Grant·A
Chief Medical Officer
$0
67.5K sh
Own New
-
Grant·A
Scott Kellen KEY
CFO & Secretary
$0
162.0K sh
Own New
-
Grant·A
Director
$0
40.4K sh
Own New
-
Grant·A
Director
$0
40.4K sh
Own New
-
Grant·A
Director
$0
40.4K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | Charles Pauling Semba | Grant A | 40.4K | $0 |
| Jun 1, 2026 | Dietrich John Pauls KEY | Grant A | 380.0K | $0 |
| Jun 1, 2026 | James T. Parsons | Grant A | 51.2K | $0 |
| Jun 1, 2026 | Randall Michael Giuffre | Grant A | 40.4K | $0 |
| Jun 1, 2026 | Julie Krop | Grant A | 67.5K | $0 |
| Jun 1, 2026 | Scott Kellen KEY | Grant A | 162.0K | $0 |
| Jun 1, 2026 | Tanya Lewis | Grant A | 40.4K | $0 |
| Jun 1, 2026 | Daniel J. O'Connor | Grant A | 40.4K | $0 |
| Jun 1, 2026 | Richard Kuntz | Grant A | 40.4K | $0 |
About DMAC insider trading
This page tracks insider transactions for DiaMedica Therapeutics Inc. (DMAC) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.